Mulder, P., Morrison, M. C., Verschuren, L., Liang, W., van Bockel, J. H., Kooistra, T., . . . Kleemann, R. (2016). Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice. Sci Rep.

Mulder, Petra, Martine C. Morrison, Lars Verschuren, Wen Liang, J. Hajo van Bockel, Teake Kooistra, Peter Y. Wielinga, i Robert Kleemann. "Reduction of Obesity-associated White Adipose Tissue Inflammation By Rosiglitazone Is Associated With Reduced Non-alcoholic Fatty Liver Disease in LDLr-deficient Mice." Sci Rep 2016.

Mulder, Petra, et al. "Reduction of Obesity-associated White Adipose Tissue Inflammation By Rosiglitazone Is Associated With Reduced Non-alcoholic Fatty Liver Disease in LDLr-deficient Mice." Sci Rep 2016.